Guardant Health
271 hedge funds and large institutions have $2.86B invested in Guardant Health in 2024 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 76 reducing their positions, and 53 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 76
7.38% more ownership
Funds ownership: 96.14% → 103.52% (+7.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less funds holding
Funds holding: 282 → 271 (-11)
14% less capital invested
Capital invested by funds: $3.32B → $2.86B (-$461M)
19% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 53
62% less call options, than puts
Call options by funds: $21.3M | Put options by funds: $56M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$187M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$108M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$48M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$42.5M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$33.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$83.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$52.4M |
| 3 |
Temasek Holdings
Singapore
|
-$47M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.6M |
| 5 |
Millennium Management
New York
|
-$41.9M |
GH Hedge Fund Activity: Q3 2024 in Review
271 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2024, worth a combined $2.86B — down 14% from $3.32B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of GH and 43 opened new positions — a net loss of 10 holders — while 76 trimmed existing stakes and 95 added.
The largest buyer was Wellington Management Group, adding an estimated $187M. The largest seller was Citadel Advisors, cutting an estimated $83.8M.
- 271 institutional investors held Guardant Health (GH) as of Q3 2024, down from 282 in Q2 2024.
- Funds reported $2.86B of Guardant Health stock for Q3 2024, down 14% quarter-over-quarter.
- 43 funds opened new Guardant Health positions in Q3 2024 and 53 closed out, a net change of -10 holders.
- The largest Guardant Health buyer in Q3 2024 was Wellington Management Group, an estimated $187M added.
- The largest Guardant Health seller in Q3 2024 was Citadel Advisors, an estimated $83.8M sold.
Based on aggregated 13F filings for Q3 2024.